Tampa Company Expands Clinical Trials of Cancer Vaccine

UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, is moving forward with clinical trials of a cancer vaccine after getting FDA approval. 

The company developed the vaccine after decades of research and study. Earlier trials showed promise in larger animals afflicted with melanoma. Now the company wants to test the drug on humans with two types of carcinoma. The green light from the FDA opens the door toward expanding the treatment to humans.

“The preliminary data does come out through the course of this study so we’re aware of what’s going on,” Ashraf Dehlawi, director of regulatory affairs for Morphogenesis. “There’s only so much we can disclose at this point, so it’s definitely very promising.” 

Learn more about Tampa Company Expands Clinical Trials of Cancer Vaccine.